'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Medistep Healthcare Limited
MEDISTEP (NSE) · ISIN INE0UOY01019 · Personal Care · listed 2025
Not on any surveillance list
Next: Board meeting: financial results on 2 November 2026.
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹37.82 cr | ₹5.18 cr | ₹50.3 cr |
| 30 Sep 2025 standalone | ₹34.81 cr | ₹0.59 cr | ₹42.69 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 68.96% | 0.00% | 0.00% | 31.04% |
Latest filings
- Medistep Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2026. 24 August 2026 · NSE
- Annual Report FY2025-26 (New) 24 August 2026 · NSE
- Medistep Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. 30 May 2026 · NSE
- GIRDHARILAL PRAJAPAT has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulatio 20 May 2026 · NSE
- Submission of SDD Compliance certificate under Regulation 3(5) and 3(6) of Securitiesand Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 for year endedMarch 31, 2026 30 April 2026 · NSE
Other companies in Personal Care
- Godrej Consumer Products Limited
- Dabur India Limited
- Colgate Palmolive (India) Limited
- Procter & Gamble Hygiene and Health Care Limited
- Gillette India Limited
- Emami Limited
- Honasa Consumer Limited
- Bajaj Consumer Care Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.